PTC Therapeutics PTCT Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by PTC Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The official record: PTC Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about PTC Therapeutics's total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is PTC Therapeutics's total liabilities & equity?
- PTC Therapeutics (PTCT) reported total liabilities & equity of $2.87B in Q1 2026.
- How has PTC Therapeutics's total liabilities & equity changed year-over-year?
- PTC Therapeutics's total liabilities & equity increased by 8.0% year-over-year, from $2.66B to $2.87B.
- What is the long-term trend for PTC Therapeutics's total liabilities & equity?
- Over 5 years (2020 to 2025), PTC Therapeutics's total liabilities & equity has grown at a 5.6% compound annual growth rate (CAGR), from $2.21B to $2.9B.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.